Medtronic Gains CE Mark for Euphora Semicompliant Coronary Balloon; Launches in Europe

Today Medtronic plc (NYSE: MDT) announced that its Euphora™ Semicompliant Balloon Dilatation Catheter has received the CE (Conformité Européene) mark and that the product has been launched, the first case being performed by Dr. Richard Edwards in the UK. While most think of stents when they think of interventional cardiology, balloons play an important role in percutaneous coronary interventions (PCI).
Source: News from Angioplasty.Org - Category: Cardiology Source Type: news